| Consider the Source: The Drug Dilemma
Bate, Roger; Porter, Karin
The American, May 19, 2009, online edition
"A recent case reveals that it is not only generic firms from middle-income countries that have problems with good manufacturing practice. [...] As more firms source more intermediate chemicals and active pharmaceutical ingredients from myriad countries, we may be seeing the beginning of a trend."
Roger Bates is Legatum fellow at the American Enterprise Institute (AEI). Karin Porter is a research assistant at AEI and editorial assistant at The American.
Go to the article at:
http://www.american.com/archive/2009/may-2009/consider-the-source/article_print
H9/03-09 Posted May 26, 2009
|
